Veterinary Medicine Compound Sulfamonomethoxine Sodium Injection for Swine

• Varieties: Infectious Disease Prevention Medicine
• Component: Chemical Synthetic Drugs
• Type: The First Class
• Shipping Cost: Estimated freight per unit.: about shipping cost and estimated delivery time.
• Currency: US$
• Return&refunds: You can apply for a refund up to 30 days after receipt of the products.
• Model NO.: Compound Sulfamonomethoxine Sodium Injection
• Pharmacodynamic Influential Factors: Animal Species
• Storage Method: Light Proof
• Veterinary Reg. No.: 220046171
• GMP: 22018
• Executive Standard: Chinese Veterinary Pharmacopoeia, 2015 Version
• Shelf Life: 2 Years
• Main Component: Sulfamonomethoxine Sodium, Trimethoprim
• Description: a Clear, Colorless to Slightly Yellow Liquid
• Administration: Injection
• Transport Package: Box
• Specification: 10ml/vial
• Trademark: SINDER
• Origin: Sichuan, China
• HS Code: 3004209099
• Production Capacity: 100000L/Year
• Package Size: 1.00cm * 1.00cm * 1.00cm
• Package Gross Weight: 0.100kg

Product Description

Compound Sulfamonomethoxine Sodium Injection
Veterinary Use
(Veterinary Drug name)Compound Sulfamonomethoxine Sodium Injection
(Main Component)Sulfamonomethoxine Sodium, Trimethoprim
(Description)A clear, colorless to slightly yellow liquid.
(Indications for Use)Used for infection of respiratory tract, digestive tract and urinary tract of swine caused by sensitive bacterias.
Antimicrobials. Sulfamonomethoxine has broad spectrum antibacterial activity and has a strong inhibitory effect on most gram-positive and negative bacteria. By competing with p-aminobenzoic acid in dihydrofolate synthase, Sulfamonomethoxine inhibits the synthesis of folate from sensitive bacteria. By inhibiting dihydrofolate reductase, Trimethoprim prevents dihydrofolate from being reduced to tetrahydrofolate and inhibits folate metabolism and utilization of sensitive bacteria.  The combined use of the two components can simultaneously block folate metabolism from two different links and produce synergistic antibacterial effect.
(Administration and Dosage)
Intramuscular injection: 0.2-0.3ml per 1kg weight of swine for each dosage. 1-2 dosage/day, continuously use for 2 to 3 days.
(Adverse Effect)
Excessive dose is prone to acute poisoning, mainly manifested as nerve excitement, co-agent disorder, anorexia, vomiting, diarrhea and hematopoietic function, urinary system damage.
(Precaution) 
1. This product is not suitable for use with urotropine.
2. Patients with liver and kidney insufficiency should use with caution.
3. Intramuscular injection has local stimulation.
4. Use with caution in pregnant and lactating livestock.
(Withdrawl) 
28 days.
(Specification)10ml: Sulfamonomethoxine sodium 1g + Trimethoprim 0.2g.
(Package)10ml/vial,10vials/box.
(Storage and Validity)Preserve in well closed containers, protected from light. Shelf life: 2 years.
Approval No.: Veterinary drug 220046171
Executive Standard: <Chinese Veterinary Pharmacopoeia>, 2015 version, 1^st section.
Producing License No.: (2015) Veterinary drug 22004.
Veterinary GMP Approval No.: (2015) Veterinary drug GMP No.22018.
Address: Zitong Economic zone, Mianyang, Sichuan Province, China.
 

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.